BioAge Labs Inc.

NASDAQ: BIOA · Real-Time Price · USD
4.58
0.12 (2.69%)
At close: Aug 15, 2025, 3:47 PM

BioAge Labs Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Net Income
-71.11M -63.85M -39.72M
Depreciation & Amortization
167K 162K 129K
Stock-Based Compensation
6.98M 3.02M 2.54M
Other Working Capital
11.17M 7.1M -199K
Other Non-Cash Items
1.26M 16.6M 77K
Deferred Income Tax
n/a n/a n/a
Change in Working Capital
11.18M 6.71M 795K
Operating Cash Flow
-51.52M -37.36M -36.18M
Capital Expenditures
-366K -166K -103K
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
n/a -100K n/a
Sales Maturities Of Investments
n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a
Investing Cash Flow
-366K -266K -103K
Debt Repayment
-6M 35M 2.5M
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
n/a -59K -1K
Financial Cash Flow
381.2M 34.94M 2.5M
Net Cash Flow
329.39M -2.69M -33.54M
Free Cash Flow
-51.89M -37.53M -36.28M